UnitedHealth Group: How TrumpRx Might Disrupt The Business

Since my last analysis on UnitedHealth Group (NYSE: UNH ), which was a strong buy rating, the company has appreciated by a total return of 19.91% which is certainly impressive in a month and a half. I want to revisit my theoryAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a particular interest in sectors such as Oil&Gas and consumer goods. B ...